14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.24 $11.93 Wednesday, 24th Apr 2024 FOLD stock ended at $10.54. This is 1.59% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.67% from a day low at $10.50 to a day high of $10.78.
90 days $10.24 $14.03
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
Jan 05, 2024 $13.32 $13.68 $13.32 $13.52 1 863 176
Jan 04, 2024 $13.60 $13.61 $13.15 $13.44 2 757 207
Jan 03, 2024 $13.97 $14.12 $13.46 $13.53 3 379 537
Jan 02, 2024 $14.05 $14.53 $13.85 $14.24 3 012 317
Dec 29, 2023 $14.48 $14.48 $14.13 $14.19 2 959 687
Dec 28, 2023 $14.38 $14.57 $14.26 $14.52 2 405 801
Dec 27, 2023 $14.15 $14.44 $13.97 $14.43 2 583 875
Dec 26, 2023 $13.70 $14.15 $13.66 $14.09 2 718 402
Dec 22, 2023 $13.30 $13.63 $13.18 $13.60 3 132 423
Dec 21, 2023 $13.03 $13.29 $12.71 $13.16 2 780 916
Dec 20, 2023 $13.10 $13.30 $12.80 $12.84 2 401 477
Dec 19, 2023 $13.25 $13.32 $13.00 $13.18 3 537 014
Dec 18, 2023 $12.70 $12.75 $12.45 $12.66 2 409 350
Dec 15, 2023 $12.57 $12.88 $12.50 $12.72 6 259 105
Dec 14, 2023 $12.50 $12.81 $12.32 $12.45 4 582 914
Dec 13, 2023 $11.82 $12.33 $11.76 $12.33 3 426 176
Dec 12, 2023 $11.40 $11.89 $11.11 $11.82 2 573 774
Dec 11, 2023 $11.28 $11.57 $11.21 $11.45 1 907 704
Dec 08, 2023 $11.41 $11.48 $11.19 $11.22 1 819 777
Dec 07, 2023 $11.02 $11.49 $11.02 $11.47 2 131 519
Dec 06, 2023 $11.19 $11.29 $10.96 $11.02 1 559 798
Dec 05, 2023 $10.90 $11.16 $10.83 $11.11 3 825 375
Dec 04, 2023 $11.13 $11.37 $10.99 $11.10 1 977 516
Dec 01, 2023 $11.05 $11.23 $10.86 $11.22 1 752 236
Nov 30, 2023 $10.90 $11.21 $10.78 $11.02 2 210 817
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT